shares
Litek Pharma receives the CEBEK Emprende 2026 Award: a recognition we would like to share and sincerely appreciate
At Litek Pharma, we are proud to announce that we have been honored with the CEBEK Emprende 2026 Award, a recognition that we receive with great satisfaction and, above all, with deep gratitude toward all the people, customers, collaborators, and professionals who have been part of our journey.
This award represents an important motivation for us to continue advancing our mission: to develop innovative solutions for aseptic and containment processes in the pharmaceutical and biotechnology industries, contributing to improved drug manufacturing processes and supporting the development of therapies that have a real impact on people’s lives.
A recognition of collective effort
The CEBEK Emprende 2026 Award jury highlighted our specialization in the design and manufacturing of advanced solutions for pharmaceutical processes, our international vision, and our strong technological focus.
At Litek Pharma, we work every day to develop technologies capable of addressing the challenges of an increasingly demanding industry, especially in critical environments where safety, quality, and regulatory compliance are essential.
This recognition also reinforces our commitment to innovation in the production of highly critical sterile medicines and acknowledges our ability to integrate engineering, automation, and regulatory compliance into every project.
Our gratitude to CEBEK and its role in supporting the business ecosystem
We would like to express our sincere thanks to CEBEK for this recognition and for the important work it carries out in supporting business growth, entrepreneurship, and innovation.
For many years, CEBEK has played a fundamental role in supporting companies, promoting initiatives, and creating opportunities that encourage economic development, talent, and new business growth. Its commitment to the business ecosystem contributes significantly to strengthening the industrial landscape and fostering projects capable of shaping the future.
Receiving recognition from an organization with such a strong track record and impact makes this award especially meaningful for us.
Thanks to everyone who is part of Litek Pharma
We would like to dedicate this recognition especially to the entire Litek Pharma team. This award is the result of the effort, dedication, and daily commitment of professionals who work passionately to drive innovative solutions within the pharmaceutical and biotechnology sectors.
We would also like to thank our customers, partners, and collaborators for their trust and confidence. Their support has been fundamental to our growth and has encouraged us to continue developing increasingly ambitious projects.
Moving forward toward the future
At Litek Pharma, we continue working on the development of advanced solutions such as pharmaceutical isolators, RABS (Restricted Access Barrier Systems), Fill & Finish technologies, and other solutions designed to optimize critical processes and contribute to safer and more efficient sterile manufacturing.
Receiving the CEBEK Emprende 2026 Award represents much more than a business achievement for us. It is an additional motivation to continue innovating, growing, and embracing new challenges with the same enthusiasm with which we started.
Thank you for being part of this journey.


